Global Endocrine Laboratory Testing Market US$ 10.

5 Billion by 2021

The global endocrine laboratory testing market expected to reach US$ 10.5 billion by 2021, growing at CAGR 7.8%
over the forecast period 2017-2021, due to increasing incidences of endocrine disorders and rising geriatric
population worldwide.

The endocrine system consisting of several glands such as pineal, pituitary, and thyroid and secretory organs such
as hypothalamus and pancreas, releases hormones directly into the blood stream and regulate the body functioning.
Some hormones (cortisol, follicle-stimulating hormone, luteinizing hormone) have a daily or monthly pattern of
release. Other hormones are generally present in very small quantities in the blood and are released in specific
situations, such as the release of epinephrine (adrenaline) from the adrenal glands in response to stress. The
endocrine laboratory tests help in detecting the deviations in the secretion of the hormones to understand the
disorders like infertility, menopause, thyroid dysfunction. The major driving factors of endocrine laboratory testing
market includes increasing health care awareness rise of endocrine disorders such as diabetes, thyroid disorders,
and infertility, and advancement of the technology.

Browse Endocrine Laboratory Testing Market by Test Type (Cortisol Test, Dehydroepiandrosterone Sulfate Test,
Estradiol Test, Follicle Stimulating Hormone Test, Human Chorionic Gonadotropin Test, Insulin Test, Luteinizing
Hormone Test, Progesterone Test, Prolactin Test, Testosterone Test, Thyroid Stimulating Hormone Test, Others -
Gastrin, Thymosin, Secretin), Technology (Tandem Mass Spectrometry, Immunoassay Technologies, Monoclonal
and Polyclonal Antibody Technologies, Sensor Technologies, Clinical Chemistry Technologies, Other Technologies),
End Users (Hospitals, Commercial Laboratories, Ambulatory Care Centers, Home-based Tests, Physician Offices,
Others) and Forecast 2017-2021 at https://www.ihealthcareanalyst.com/report/endocrine-laboratory-testing-
market/

The global endocrine laboratory testing market report provides market size (Revenue USD Million 2014 to 2021),
market share, trends and forecasts growth trends (CAGR%, 2017 to 2021). The global endocrine laboratory testing
market research report is further segmented by geography into North America (U.S., Canada), Europe (U.K.,
Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), Latin America (Brazil,
Mexico, Rest of LA), and Rest of the World. The global endocrine laboratory testing market report also provides the
detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks
the major competitors operating in the market by company overview, financial snapshot, key products, technologies
and services offered, market share analysis and recent trends in the global market.

Major players operating in the global endocrine laboratory testing market and profiled in this report include Abbott
Laboratories, AB Sciex Pte. Ltd., Agilent Technologies, Biomedical Diagnostics, bioMerieux SA, Bio-Rad Laboratories,
DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Laboratory Corporation of America Holdings (LabCorp), Ortho-Clinical
Diagnostics, Quest Diagnostics, Siemens Healthcare GmbH (Siemens AG), Sysmex Corporation., and Thermo Fisher
Scientific, Inc.

1. Test Type
1.1. Cortisol Test
1.2. Dehydroepiandrosterone Sulfate (DHEAS) Test
1.3. Estradiol (E2) Test
1.4. Follicle Stimulating Hormone (FSH) Test
1.5. Human Chorionic Gonadotropin (hCG) Test
1.6. Insulin Test
1.7. Luteinizing Hormone (LH) Test
1.8. Progesterone (P4) Test
1.9. Prolactin Test
1.10. Testosterone Test
1.11. Thyroid Stimulating Hormone (TSH) Test
 1.12. Others (Gastrin, Thymosin, Secretin, etc.)

2. Technology
2.1. Tandem Mass Spectrometry
2.2. Immunoassay Technologies
2.3. Monoclonal and Polyclonal Antibody Technologies
2.4. Sensor Technologies
2.5. Clinical Chemistry Technologies
2.6. Other Technologies

3. End Users
3.1. Hospitals
3.2. Commercial Laboratories
3.3. Ambulatory Care Centers
3.4. Home-based Tests
3.5. Physician Offices
3.6. Others

4. Geography (Region, Country)

4.1. North America (U.S., Canada)
4.2. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
4.3. Latin America (Brazil, Mexico, Rest of LA)
4.4. Asia Pacific (Japan, China, India, Rest of APAC)
4.5. Rest of the World (Middle East & Africa)

5. Company Profiles
5.1. Abbott Laboratories
5.2. AB Sciex Pte. Ltd.
5.3. Agilent Technologies
5.4. Biomedical Diagnostics
5.5. bioMerieux SA
5.6. Bio-Rad Laboratories
5.7. DiaSorin S.p.A.
5.8. F. Hoffmann-La Roche Ltd.
5.9. Laboratory Corporation of America Holdings (LabCorp)
5.10. Ortho-Clinical Diagnostics
5.11. Quest Diagnostics
5.12. Siemens Healthcare GmbH (Siemens AG)
5.13. Sysmex Corporation.
5.14. Thermo Fisher Scientific, Inc.

To request Table of Contents and Sample Pages of this report visit:

https://www.ihealthcareanalyst.com/report/endocrine-laboratory-testing-market/

About Us

iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis,
and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting
grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics,
healthcare services, medical devices, medical equipment, and pharmaceuticals.
In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client
assignments targeted at clients specific business objectives, information needs, time frame and budget. Please
contact us to receive a proposal for a proprietary single-client study.

Contact Us

iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareanalyst.com
Website: https://www.ihealthcareanalyst.com